TY - JOUR
T1 - Survivorship, version 2.2018
T2 - Clinical practice guidelines in oncology
AU - Denlinger, Crystal S.
AU - Sanft, Tara
AU - Baker, K. Scott
AU - Broderick, Gregory
AU - Demark-Wahnefried, Wendy
AU - Friedman, Debra L.
AU - Goldman, Mindy
AU - Hudson, Melissa
AU - Khakpour, Nazanin
AU - King, Allison
AU - Koura, Divya
AU - Lally, Robin M.
AU - Langbaum, Terry S.
AU - McDonough, Allison L.
AU - Melisko, Michelle
AU - Montoya, Jose G.
AU - Mooney, Kathi
AU - Moslehi, Javid J.
AU - O'Connor, Tracey
AU - Overholser, Linda
AU - Paskett, Electra D.
AU - Peppercorn, Jeffrey
AU - Pirl, William
AU - Rodriguez, M. Alma
AU - Ruddy, Kathryn J.
AU - Silverman, Paula
AU - Smith, Sophia
AU - Syrjala, Karen L.
AU - Tevaarwerk, Amye
AU - Urba, Susan G.
AU - Wakabayashi, Mark T.
AU - Zee, Phyllis
AU - McMillian, Nicole R.
AU - Freedman-Cass, Deborah A.
N1 - Publisher Copyright:
© 2018 JNCCN - Journal of the National Comprehensive Cancer Network.
PY - 2018/10/1
Y1 - 2018/10/1
N2 - The NCCN Guidelines for Survivorship provide screening, evaluation, and treatment recommendations for common physical and psychosocial consequences of cancer and cancer treatment to help healthcare professionals who work with survivors of adult-onset cancer in the posttreatment period. This portion of the guidelines describes recommendations regarding the management of anthracycline-induced cardiotoxicity and lymphedema. In addition, recommendations regarding immunizations and the prevention of infections in cancer survivors are included.
AB - The NCCN Guidelines for Survivorship provide screening, evaluation, and treatment recommendations for common physical and psychosocial consequences of cancer and cancer treatment to help healthcare professionals who work with survivors of adult-onset cancer in the posttreatment period. This portion of the guidelines describes recommendations regarding the management of anthracycline-induced cardiotoxicity and lymphedema. In addition, recommendations regarding immunizations and the prevention of infections in cancer survivors are included.
UR - http://www.scopus.com/inward/record.url?scp=85054891584&partnerID=8YFLogxK
U2 - 10.6004/jnccn.2018.0078
DO - 10.6004/jnccn.2018.0078
M3 - Review article
C2 - 30323092
AN - SCOPUS:85054891584
SN - 1540-1405
VL - 16
SP - 1216
EP - 1247
JO - JNCCN Journal of the National Comprehensive Cancer Network
JF - JNCCN Journal of the National Comprehensive Cancer Network
IS - 10
ER -